Literature DB >> 11804837

A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization.

Michihiro Suzuki1, Shiro Maeyama, Noriaki Okuse, Kouji Nishikawa, Yutaro Kobayashi, Yasuto Takahashi, Chiaki Okuse, Taturo Osada, Takeshi Hayashi, Hiroshi Yotuyanagi, Masao Takatori, Seiichiro Ogata, Toshiyuki Uchikoshi, Shiro Iino.   

Abstract

The patient was a 49-year-old male under observation for chronic hepatitis B. In July 1997, abdominal ultrasonography showed multiple hyperechoic nodules in the right lobe, the largest with a diameter of 3.5 cm. Abdominal computed tomography did not reveal enhanced nodules, and the patient was hospitalized for suspected multiple liver tumors. All biochemical tests were normal, except for a slight decrease in platelets. The patient was positive for HBs antigen, negative for HBe antigen and positive for anti-HBe antibody. Hepatocellular carcinoma (HCC) with patent portal blood flow was strongly suspected based on the results of various imaging techniques. A tumor biopsy was conducted, and findings of multiple early hepatocellular carcinoma of a well-differentiated type were observed. Based on the HCC stage and liver function, an extensive right hepatectomy was indicated. Before the surgical resection, a percutaneous transhepatic portal embolization (PTPE) was performed using gerfoam sponzel in the right portal vein. Complete necrosis of the tumor lesions was observed in the resected liver. Early HCC thought to have developed multifocally concurrently with chronic inactive hepatitis was observed. It is highly possible that complete necrosis of these tumors occurred due to PTPE, suggesting that they are supplied by the portal blood flow.

Entities:  

Year:  2002        PMID: 11804837     DOI: 10.1016/s1386-6346(01)00117-6

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  2 in total

1.  Necrosis of large hepatocellular carcinoma induced by preoperative portal vein embolization: a case report.

Authors:  Akira Yasuda; Tsuyoshi Kurokawa; Noiku Nakao; Hiroyuki Fujisaki; Keiichi Ando; Nobuhiro Ito; Norifumi Ohashi; Takashi Arikawa; Takahisa Tainaka; Hiroshi Nagata; Kazuyoshi Suzumura; Toshiaki Nonami
Journal:  Dig Dis Sci       Date:  2013-04-16       Impact factor: 3.199

Review 2.  Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma.

Authors:  Toru Beppu; Kensuke Yamamura; Hirohisa Okabe; Katsunori Imai; Hiromitsu Hayashi
Journal:  Ann Gastroenterol Surg       Date:  2020-12-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.